Tiedemann Trust’s AbbVie ABBV Stock Holding History

Tiedemann Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$405K	Hold	6,540	–	–	0.07%	50
2016 Q1	$374K	Buy	6,540 +1,214	+23%	+$67.7K	0.06%	56
2015 Q4	$316K	Buy	+5,326	New	+$307K	0.05%	65
2015 Q3	–	Sell	-5,326	Closed	-$358K	–	56
2015 Q2	$358K	Buy	+5,326	New	+$348K	0.03%	58
2014 Q1	–	Sell	-2,691	Closed	-$256K	–	84
2013 Q4	$256K	Sell	2,691 -4,136	-61%	-$203K	0.04%	70
2013 Q3	$305K	Sell	6,827 -223	-3%	-$9.88K	0.05%	53
2013 Q2	$291K	Buy	+7,050	New	+$308K	0.05%	92

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tiedemann Trust's ABBV Position: Q2 2016 in Review

Tiedemann Trust held its AbbVie (ABBV) position steady in Q2 2016 at 6,540 shares worth $405K. The position accounts for 0.07% of the portfolio, ranked #50.

Tiedemann Trust first reported a position in ABBV in Q2 2013 and has held it in 7 quarters since. 1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

Tiedemann Trust held 6,540 shares of AbbVie worth $405K as of Q2 2016.
Tiedemann Trust left its AbbVie share count unchanged in Q2 2016.
AbbVie made up 0.07% of Tiedemann Trust's portfolio in Q2 2016, its #50 holding.
Tiedemann Trust first reported a position in AbbVie in Q2 2013 and has held it in 7 quarters since.
1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Tiedemann Trust's 13F filing for Q2 2016, filed 12 Aug 2016.